Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2
- PMID: 32801224
- PMCID: PMC7853271
- DOI: 10.4103/ijmr.IJMR_2609_20
Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2
Conflict of interest statement
Comment in
-
Prophylactic use of hydroxychloroquine among healthcare workers in a case-control study.Indian J Med Res. 2020 Jul & Aug;152(1 & 2):127-128. doi: 10.4103/ijmr.IJMR_2434_20. Indian J Med Res. 2020. PMID: 32773428 Free PMC article. No abstract available.
-
Authors' response.Indian J Med Res. 2020 Jul & Aug;152(1 & 2):125-126. doi: 10.4103/0971-5916.292028. Indian J Med Res. 2020. PMID: 32801225 Free PMC article. No abstract available.
Comment on
-
Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.Indian J Med Res. 2020 May;151(5):459-467. doi: 10.4103/ijmr.IJMR_2234_20. Indian J Med Res. 2020. PMID: 32611916 Free PMC article.
References
-
- Browning DJ. Pharmacology of chloroquine and hydroxychloroquine Hydroxychloroquine and chloroquine retinopathy. New York: Springer; 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous